More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms after a year on the drug, researchers reported March 6 in The New England ...

It's a sad and inconvenient fact that many drugs have to be administered in the form of a slow intravenous (IV) drip, as opposed to a single quick injection. That may be about to change, however, ...

Hepatitis C is a viral infection that causes liver inflammation and, at times, results in major damage to your liver. The virus that causes it spreads through blood and other bodily fluids. If you ...

Credit: Hikma. The treatment is indicated for shorter-term use (5 days or less). Care should be taken when prescribing and preparing Combogesic IV so that dosing errors are avoided. Combogesic ® IV ...

The Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the disease, may be able to be given as a set of two weekly shots at home, a study from drugmaker Eisai suggests, ...

A team of scientists has uncovered the mechanism of cellular uptake for large and polar drugs and devised a novel strategy to optimize the capacity of drug-delivery into these cells. The team was led ...

A research team has developed an intravenous (IV) needle that softens upon insertion, minimizing risk of damage to blood vessels and tissues. Once used, it remains soft even at room temperature, ...

A new study has found that specific regions of the brain are activated after a drug is taken intravenously but not when the same drug is taken orally, with increased activity correlating to an ...

Purpose: The frequency of drug administration errors and incompatibilities between intravenous drugs before and after an intervention in an intensive care unit (ICU) is discussed. Methods: Critically ...

A recent study published in the Journal of Controlled Release demonstrated a novel method for delivering anti-cancer drugs conjugated to modified cell-penetrating peptides across the blood-brain ...